| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 31, 638-641, Copyright © 1984 by Canadian Anesthesiologists' Society
1 Department of Anaesthesiology, University of California, School of Medicine, Sacramento, California
Address correspondence to: Dr. Amira M. Safwat, University of California, Davis Medical Center, Department of Anesthesiology, 2315 Stockton Boulevard, Sacramento, California 95817.
Forty patients ASA physical status I-III were selected and divided into four groups. Group I, Control, received saline pretreatment five minutes prior to rapid sequence induction and intubation, while Groups II, III and IV receivedpropranolol 0.01 mg·kg-1 IV two, five or eight minutes prior to induction and intubation. Measurements of heart rate (HR), arterial blood pressure (ABP) were recorded as baseline values and at one, two, five, eight and 20 minutes, and simultaneous venous samples were withdrawn for propranolol levels. Calculated rate pressure product (RPP) showed best haemodynamic control in Group III. Serum propranolol levels were under 5 ng·ml-1 in Group III and undetectable in Group IV. Our data show that the optimal time interval between IV propranolol administration and intubation was five minutes.
Key Words: SYMPATHETIC NERVOUS SYSTEM, SYMPATHOLYTIC AGENTS: propranolol ANAESTHETIC TECHNIQUES: rapid sequence induction COMPLICATIONS: hypertension, tachycardia
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |